February 25, 2019 by Chain Drug Review
Centers for Medicare and Medicaid Services (CMS), Health and Human Services Secretary Alex Azar, NACDS, Rep. Cathy McMorris Rodgers
Leading Headlines, Pharmacy
ARLINGTON, Va. — Rep. Cathy McMorris Rodgers (R, Wash.), a consistently pro-pharmacy advocate, led a letter to Health and Human Services Secretary Alex Azar urging support for provisions in the recently released proposed rule—Modernizing Part D and Medicare Advantage to Lower Prices and Reduce Out-of-Pocket Expenses—by the Centers for Medicare and Medicaid Services (CMS). The
February 18, 2019 by Chain Drug Review
Alex Azar, NACDS
February 18, 2019, News
WASHINGTON — The National Association of Chain Drug Stores and the National Community Pharmacists Association (NCPA) have praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar. The letter thanked the secretary for concepts in the Centers for Medicare and Medicaid Services’ (CMS’) proposed rule, Modernizing Part D and Medicare Advantage to
February 18, 2019 by Jeffrey Woldt
2019 NACDS Regional Chain Conference, DIR fees, Mark Panzer, Medicare Part D, NACDS, Steve Anderson
February 18, 2019, Opinion
The National Association of Chain Drug Stores was at the top of its game during the Regional Chain Conference in Palm Beach, Fla., earlier this month. Often overshadowed by the association’s larger events, this hidden gem provides attendees with an initial look at the objectives that NACDS and its members will pursue during the course
February 14, 2019 by Steven Anderson
NACDS, NACDS RxImpact Day on Capitol Hill, Steven Anderson
Leading Headlines, Opinion, Pharmacy
ARLINGTON, Va. — In just over two weeks, pharmacy advocates from all 50 states will travel to Washington, D.C. for NACDS RxIMPACT Day on Capitol Hill. With direct and indirect remuneration (DIR) fee reform headlining the agenda, this event will make a powerful statement to the Trump Administration and to Congress about the crucial need
February 13, 2019 by Chain Drug Review
NACDS, NACDS Annual Meeting, Paul Ryan
Leading Headlines
ARLINGTON, Va. – Paul Ryan, former speaker of the House, will speak during the Tuesday, April 30, Business Program at the 2019 NACDS Annual Meeting, which will be held April 27-30, in Palm Beach, Fla. Ryan was elected as the 54th speaker in 2015 and served until January 2019. Ryan was first elected to the House
February 13, 2019 by Chain Drug Review
Lionel Richie, NACDS, NACDS Annual Meeting
Leading Headlines
PALM BEACH — Lionel Richie, one of the world’s biggest stars in music, will headline the NACDS Annual Meeting, which will be held April 27-30 at The Breakers. The multi award winning singer/songwriter will perform on Tuesday, April 30 from 7:30 p.m. to 11:00 p.m. Open to ticket holders only.
February 4, 2019 by Chain Drug Review
2019 National Drug Control Strategy, NACDS, pharmacy, Steven Anderson
Leading Headlines, Pharmacy
ARLINGTON, Va.— The National Association of Chain Drug Stores (NACDS) today welcomed the White House’s release of the 2019 National Drug Control Strategy, and expressed in particular the Association’s commitment to collaboration as part of the solution to the opioid-abuse epidemic. “We have an opportunity to continue to build on longstanding and ongoing efforts to
February 4, 2019 by Chain Drug Review
DIR fee reform, NACDS
February 4, 2019, News
ARLINGTON, Va. — The National Association of Chain Drug Stores has submitted extensive and thoroughly documented comments to the Centers for Medicare and Medicaid Services (CMS) in support of the agency’s proposal to reform direct and indirect remuneration (DIR) fees — reform that relates directly to reducing patients’ out-of-pocket drug costs. NACDS issued its comments
January 31, 2019 by Chain Drug Review
NACDS, pharmacists, pharmacy, Steve Anderson
Leading Headlines
ARLINGTON, Va. – The National Association of Chain Drug Stores has responded to “The Unsung Role of the Pharmacist in Patient Health,” a New York Times article published on Jan. 28 that emphasizes the increasingly important role of pharmacists in health care delivery. NACDS president and CEO Steve Anderson wrote, “This column validates further the competence,
January 29, 2019 by Chain Drug Review
NACDS, pharmacy
Featured Articles, Leading Headlines, Pharmacy
ARLINGTON, Va. – The National Association of Chain Drug Stores has promoted six staff members to roles vital to the advancement of the NACDS Access Agenda and its related issue campaigns. Michael Angeloni was named government affairs and communications associate. He had been government affairs coordinator. Christie Boutte was appointed vice president of regulatory advocacy and
January 28, 2019 by Chain Drug Review
NACDS
Videos
The 2019 NACDS Regional Chain Conference is just around the corner—February 3-5 in Palm Beach, Florida. Watch this video to find out what you need to know before you go.
January 28, 2019 by Chain Drug Review
Department of Health and Human Services’ (HHS) Healthy People 2030 initiative, NACDS, Steven Anderson
Leading Headlines, Pharmacy
ARLINGTON, Va.—The National Association of Chain Drug Stores (NACDS) has submitted comments containing recommendations for the Department of Health and Human Services’ (HHS) Healthy People 2030 initiative, which develops a new set of evidence-based, 10-year national objectives aimed at improving the health of all Americans. NACDS’ comments highlight the exceptional value of community pharmacy, in
January 10, 2019 by Steve Anderson
NACDS, Steve Anderson
Featured Articles, Leading Headlines, Pharmacy
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. In health policy, 2018 and 2019 could look a lot alike. In October, the National Association of Chain Drug Stores was invited to the White House for two bill-signing ceremonies in as many weeks: one for legislation related to drug
January 9, 2019 by Chain Drug Review
Centers for Medicare & Medicaid Services’ (CMS), direct and indirect remuneration (DIR) fee reform concepts, NACDS
Leading Headlines, Pharmacy
ARLINGTON, Va. — Each NACDS member company has a powerful opportunity to submit official comments to the Centers for Medicare & Medicaid Services (CMS) in support of direct and indirect remuneration (DIR) fee reform concepts described in the agency’s proposed rule, “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses.” The